OpenAI acquires Orchestra Bio

T1Covered by 1 source · first reported by OpenAI News at 20 Oct, 00:00 UTC

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.